Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bethany Baumgart

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|March 15, 2019
Cochlear Implantation in Patients With Neurofibromatosis Type 2Anthony M Tolisano, Bethany Baumgart, Johanna Whitson, et al.
The Annals of Otology, Rhinology, and Laryngology|November 19, 2019
Identifying Disadvantaged Groups for Cochlear Implantation: Demographics from a Large Cochlear Implant ProgramAnthony M Tolisano, Natalie Schauwecker, Bethany Baumgart, et al.
Cancer Chemotherapy and Pharmacology|March 12, 2017
In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertensionBethany Baumgart, Mausumee Guha, James Hennan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|March 15, 2019
Cochlear Implantation in Patients With Neurofibromatosis Type 2Anthony M Tolisano, Bethany Baumgart, Johanna Whitson, et al.
The Annals of Otology, Rhinology, and Laryngology|November 19, 2019
Identifying Disadvantaged Groups for Cochlear Implantation: Demographics from a Large Cochlear Implant ProgramAnthony M Tolisano, Natalie Schauwecker, Bethany Baumgart, et al.
Cancer Chemotherapy and Pharmacology|March 12, 2017
In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertensionBethany Baumgart, Mausumee Guha, James Hennan, et al.
Pageof 1